GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chia Tai Enterprises International Ltd (HKSE:03839) » Definitions » Current Deferred Revenue

Chia Tai Enterprises International (HKSE:03839) Current Deferred Revenue : HK$0 Mil (As of Jun. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Chia Tai Enterprises International Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Chia Tai Enterprises International's current deferred revenue for the quarter that ended in Jun. 2024 was HK$0 Mil.

Chia Tai Enterprises International Current Deferred Revenue Historical Data

The historical data trend for Chia Tai Enterprises International's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chia Tai Enterprises International Current Deferred Revenue Chart

Chia Tai Enterprises International Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Current Deferred Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Chia Tai Enterprises International Quarterly Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Chia Tai Enterprises International Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of Chia Tai Enterprises International's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Chia Tai Enterprises International Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chia Tai Enterprises International Ltd (HKSE:03839) » Definitions » Current Deferred Revenue
Comparable Companies
HKSE:00455 HKSE:00897 HKSE:08329 HKSE:01498 HKSE:01652 HKSE:01312 HKSE:00858 HKSE:00575 HKSE:08622 HKSE:01011 ZTS XTER:MRK NSE:SUNPHARMA LSE:HLN TSE:4502 XSWX:GALD XTAE:TEVA NSE:DIVISLAB XSWX:SDZ VTRS
Traded in Other Exchanges
CAIHF:USA
Address
16 Harcourt Road, 21st Floor, Far East Finance Centre, Hong Kong, HKG
Website
http://www.ctei.com.hk
Chia Tai Enterprises International Ltd is engaged in the manufacture and sale of chlortetracycline (CTC) and animal health products. The company's operating segment includes Biochemical operations and Industrial operations. It generates maximum revenue from the Biochemical operations segment, which is engaged in the manufacture and sale of chlortetracycline and animal health products. The Industrial segment is into trading of machinery and the manufacture and sale of automotive parts through the group's joint venture and associate. Its geographical segments are Mainland China which generates key revenue, Asia Pacific (excluding mainland China), Americas, Europe, and Others.

Chia Tai Enterprises International Headlines

No Headlines